Additive Benefits of Pravastatin and Aspirin to Decrease Risks of Cardiovascular Disease

Discussion in 'Health and medical' started by listener, Mar 2, 2004.

  1. listener

    listener Guest

    "In randomized trials of secondary prevention, pravastatin sodium and aspirin reduce risks of
    cardiovascular disease. Pravastatin has a predominantly delayed antiatherogenic effect, and aspirin
    has an immediate antiplatelet effect, raising the possibility of additive clinical benefits. "


    "More widespread and appropriate combined use of statins and aspirin in secondary prevention of
    cardiovascular disease will avoid large numbers of premature deaths. "